SWK HoldingsSWKH
About: SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
Employees: 24
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
0% more funds holding
Funds holding: 52 [Q3] → 52 (+0) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]
4.3% less ownership
Funds ownership: 91.85% [Q3] → 87.56% (-4.3%) [Q4]
14% less capital invested
Capital invested by funds: $196M [Q3] → $170M (-$26.7M) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for SWKH.
Financial journalist opinion
Based on 4 articles about SWKH published over the past 30 days



